F. Hoffmann-La Roche Ltd
UkraineAll drugs from this manufacturer
-
The drug is intended for the treatment of adult patients with HER2-positive breast cancer. It is used in early-stage cancer (neoadjuvant therapy before treatment or adjuvant therapy after it), as well as in metastatic or locally recurrent breast cancer in combination with docetaxel.
Dosage form: solution for injection
Active substance Dosage pertuzumab 600 mg trastuzumab 600 mg ATC: L01FY01
-
The drug is used for the treatment of adult patients with HER2-positive early breast cancer (both pre- and post-surgery), as well as for the treatment of HER2-positive metastatic or locally recurrent unresectable breast cancer in combination with chemotherapy.
Dosage form: solution for injection
Active substance Dosage pertuzumab 1200 mg trastuzumab 600 mg ATC: L01FY01